Company intelligence / Profile preview

iOBX

Lebanon, Tennessee, United Statesiobx.com ↗

Ownership: Private
Employees: ~30
Development stage: Commercial

Overview

iOBX provides advanced, evidence-based autologous stem cell and platelet-rich plasma therapies for orthopedic conditions. The company reports high patient satisfaction rates (>90% success for joint pain) with thousands of procedures performed. Treatments are customized per patient using real-time adaptation of harvested cells, with all processing done in an on-site lab by board-certified physicians.

Therapeutic areas: OtherRheumatology
Modalities: Stem cell therapyPlatelet-rich plasma therapy (PRP)Cell therapy
Industry: Non-Academic Healthcare

Drug pipeline

3 assets

STEMISH

Commercial

Indications: Joint pain, Arthritis

2 more assets in the full pipeline.

Request access →

Partnerships

No major pharmaceutical or biotech partnerships disclosed.

Beyond the preview

Go deeper on iOBX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iOBX.

Explore the full profile